Table 1 Characteristics of the proposed participating sites
Region | Population in 2007 | Estimated ascertainment | Source of laboratory surveillance | Clinical and outcome data | Start of independent routine surveillance |
|---|---|---|---|---|---|
Calgary Health Region, Canada | 1.24 million | ≥99% | Regional microbiology laboratory | Routinely available | 2000 |
Canberra Region, Australia | 380,000 | ≥95% | Two public and one private laboratories | Routinely available | 1998 |
Finland | 5.30 million | 100% | National Infectious Disease Register | Possible though database linkage | 1995 |
North Denmark Region, Denmark | 580,000 | 100% | Regional microbiology laboratory | Routinely available | 1981 |
Sherbrooke, Canada | 152,000 | ≥99% | Regional microbiology laboratory | Routinely available | 1999 |
Vancouver Island Health Authority, Canada | 746,000 | ≥99% | Regional microbiology laboratory | Possible though database linkage | 2008 |